AUPN380695A0 - Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions - Google Patents
Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditionsInfo
- Publication number
- AUPN380695A0 AUPN380695A0 AUPN3806A AUPN380695A AUPN380695A0 AU PN380695 A0 AUPN380695 A0 AU PN380695A0 AU PN3806 A AUPN3806 A AU PN3806A AU PN380695 A AUPN380695 A AU PN380695A AU PN380695 A0 AUPN380695 A0 AU PN380695A0
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- isolation
- compounds
- methods related
- ischaemic conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN3806A AUPN380695A0 (en) | 1995-06-23 | 1995-06-23 | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
AU61152/96A AU6115296A (en) | 1995-06-23 | 1996-06-21 | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
PCT/AU1996/000381 WO1997000678A1 (en) | 1995-06-23 | 1996-06-21 | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN3806A AUPN380695A0 (en) | 1995-06-23 | 1995-06-23 | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPN380695A0 true AUPN380695A0 (en) | 1995-07-20 |
Family
ID=3788145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPN3806A Abandoned AUPN380695A0 (en) | 1995-06-23 | 1995-06-23 | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPN380695A0 (en) |
WO (1) | WO1997000678A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2805463B1 (en) * | 2000-02-25 | 2003-01-24 | Adir | USE OF TRIMETAZIDINE FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ACYL-CoA ACETYLTRANSFERASE |
WO2003037323A2 (en) * | 2001-10-26 | 2003-05-08 | MEDIGENE AG Gesellschaft für Molekularbiologische Kardiologie und Onkologie | Inhibitors of the fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
GB0405381D0 (en) | 2004-03-10 | 2004-04-21 | Univ Wales Medicine | A method and means for treating heart failure |
EP1737452A1 (en) * | 2004-04-06 | 2007-01-03 | Angiogenetics Sweden AB | Angiogenesis-affecting compounds and methods of use thereof |
GB0908193D0 (en) | 2009-05-13 | 2009-06-24 | Albright Patents | Treatment of disease state |
EP2432470A1 (en) | 2009-05-20 | 2012-03-28 | Heart Metabolics Limited | Treatment of heart failure with normal ejection fraction |
CN104138378A (en) * | 2013-05-06 | 2014-11-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | An oral pharmaceutical composition improving anoxia endurance |
GB201308736D0 (en) * | 2013-05-15 | 2013-06-26 | Univ Aberdeen | Compounds and their therapeutic use |
-
1995
- 1995-06-23 AU AUPN3806A patent/AUPN380695A0/en not_active Abandoned
-
1996
- 1996-06-21 WO PCT/AU1996/000381 patent/WO1997000678A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997000678A1 (en) | 1997-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5674696A (en) | Compounds that bind to p185 and methods of using the same | |
AU7443496A (en) | Treatment of migraine | |
AU6056698A (en) | Process for the isolation and purification of lycopene crystals | |
AU7419096A (en) | Treatment of vegetables | |
ZA961344B (en) | Process for the preparation of thietanones | |
SG55239A1 (en) | Process for the preparation of dihaloazpyrimidines | |
AU4958096A (en) | Process for the treatment of gases | |
ZA966240B (en) | Methods for treatment of allergic asthma. | |
AU2734895A (en) | Process for the preparation of 3-aryluracils | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
AU2821295A (en) | Compositions and methods for the treatment of tumors | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
AUPN380695A0 (en) | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU5486396A (en) | Process for the preparation of spiroindolines | |
AU7096496A (en) | Process for the preparation of 4-methylenepiperidines | |
AU5699396A (en) | Compositions for the treatment of skin conditions | |
AU7141196A (en) | Articles of bedding | |
EP0761720A3 (en) | Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides | |
IL115090A0 (en) | Process for the preparation of p-bromofluorobenzene | |
AU6115296A (en) | Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions | |
AU7113996A (en) | Methods of treating beta-amyloid-associated conditions | |
AUPM836794A0 (en) | Improved method and composition for the treatment of ulcers | |
IL118747A0 (en) | Process for the preparation of 3-hydroxyoxetanes | |
IL118732A (en) | Process for the preparation of arylidene-substituted alkylcycloalkanones |